Lv52
850 积分 2024-03-21 加入
Reply to: “Improved basic performance of iTACT-HBcrAg assay” and “Using a commercial diagnostic assay requires compliance with the manufacturer's recommendations”
12天前
已完结
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
12天前
已完结
Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase
15天前
已完结
High Genetic Variability of Hepatitis B Virus in Blood Donors With Surface Antigen Positive But DNA Negative in Southern China
15天前
已完结
Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
20天前
已完结
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
22天前
已完结
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
28天前
已完结
Hepatitis B virus core‐related antigen as a surrogate marker for covalently closed circular DNA
28天前
已完结
Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen–Positive Patients
1个月前
已完结
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
1个月前
已完结
皖公网安备34019202002308
